INS and metabolic dysfunction-associated steatotic liver disease: Fasting insulin, HOMA-IR, and HepFe were higher in patients in stages 2 and 3 of NAFLD as compared to stage 1 (p = 0.006, p = 0.020, and p = 0.001, respectively).